HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ultrastructural characteristics of glial fibrillary acidic protein expression in epoxy resin-embedded human brain tumors.

Abstract
Thirteen surgically removed, epoxy resin (Durcupan ACM or Epon 812)-embedded human brain tumors were examined for glial fibrillary acidic protein (GFAP) content in semithin and ultrathin sections with the immunogold-silver staining method. Mild aldehyde fixation and the hydrophobic resin embedding did not interfere with the antigenicity, since silver intensification of the immunogold marker provided excellent visualization of the reaction on both light microscopic and ultrastructural levels. The GFAP reaction was usually localized on the glial intermediate filament bundles, usually correlating well with the amount of filaments. The unstained filamental regions of two ependymomas might correspond to the vimentin expression revealed by double labeling in semithin sections. Occasional GFAP immunopositivity without filamental appearance was observed in one of the oligodendrogliomas, as patchy electron-dense cytoplasmic corpuscules, in Rosenthal fibers and in some mainly necrobiotic tumor cells, reflecting a possible connection with glial filaments.
AuthorsB Bozóky, T Krenács, Z Rázga, A Erdös
JournalActa neuropathologica (Acta Neuropathol) Vol. 86 Issue 3 Pg. 295-301 ( 1993) ISSN: 0001-6322 [Print] Germany
PMID8213089 (Publication Type: Journal Article)
Chemical References
  • Glial Fibrillary Acidic Protein
Topics
  • Astrocytoma (metabolism, ultrastructure)
  • Brain Neoplasms (metabolism, ultrastructure)
  • Ependymoma (metabolism, ultrastructure)
  • Glial Fibrillary Acidic Protein (biosynthesis)
  • Glioma (metabolism, ultrastructure)
  • Humans
  • Immunohistochemistry
  • Microscopy, Electron
  • Oligodendroglioma (metabolism, ultrastructure)
  • Plastic Embedding

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: